Airway molecular phenotypes in pediatric asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 11, Issue 2, 2011, Pages 122-126

  Aujla, Shean J ^a   Ross, Kristie R ^b   Chmiel, James F ^b   Holguin, Fernando ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Inflammatory biomarkers; molecular phenotyping; pediatric asthma

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 5; ISOPROSTANE; LEUKOTRIENE; LEUKOTRIENE E4; NITRIC OXIDE; PROSTAGLANDIN;

AIRWAY; ARTICLE; ASTHMA; CELL FUNCTION; DISEASE CLASSIFICATION; DISEASE MARKER; EPITHELIUM; EXPIRED AIR; HUMAN; INFLAMMATION; LUNG LAVAGE; OXIDATIVE STRESS; PEDIATRICS; PH; PHENOTYPE; PRIORITY JOURNAL; SPUTUM; URINE LEVEL;

ADOLESCENT; ASTHMA; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOTRIENE E4; LUNG; NITRIC OXIDE; PHENOTYPE; SPUTUM;

EID: 79952438998     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e328344874d     Document Type: Article

References (31)

1. Kim H, DeKruyff R, Umetsu D. The many paths to asthma: phenotype shaped by innate adaptive immunity. Nat Immunol 2010; 11:577-584.
2. Bush A, Menzies-Gow A. Phenotypic differences between pediatricand adult asthma. Proc Am Thorac Soc 2009; 6:712-719.
3. Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009; 180:388-395.
4. de Blic J, Tillie-Leblond I, Tonnel A, et al. Difficult asthma in children: an analysis of airway inflammation. J Allergy Clin Immunol 2004; 113:94-100. (Pubitemid 38096167)
5. Fitzpatrick A, Higgins M, Holguin F, et al. The molecular phenotype of severe asthma in children. J Allergy Clin Immunol 2010; 125:851-857.
6. Kim CK, Kita H, Callaway Z, et al. The roles of at Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation. Pediatr Allergy Immunol 2010; 21:e697-e704.
7. Gogate S, Katial R. Pediatric biomarkers in asthma: exhaled nitric oxide, sputumeosinophilsand leukotriene E4. Curr Opin Allergy Clin Immunol 2008; 8:154-157. (Pubitemid 351654312)
8. Dweik R, Sorkness R, Wenzel, et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med 2010; 181:1033-1041.
9. Fitzpatrick A, Gaston B, Erzurum S, Teague W. Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol 2006; 118:1218-1225. (Pubitemid 44854125)
10. Piacentini G, Bodini A, Costella S, et al. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur Respir J 1999; 13:1386-1390. (Pubitemid 29357157)
11. Sivan Y, Gadish T, Fireman E, Soferman R. The use of exhaled nitric oxide in the diagnosis of asthma in school children. J Pediatr 2009; 155:211-216.
12. Szefler S, Mitchell H, Sorkness C, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomized controlled trial. Lancet 2008; 372:1065-1072.
13. de Jongste J, Carraro S, Hop W, et al. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2009; 179:93-97.
14. Ko F, Leung T, Hui D. Are exhaled breath condensates useful in monitoring asthma? Curr Allergy Asthma Reports 2007; 7:65-71. (Pubitemid 46647029)
15. Zanconato S, Carraro S, Corradi M, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 2004; 113:257-263. (Pubitemid 38210547)
16. Carraro S, Cogo P, Isak I, et al. EIA and GC/MS analysis of 8-isoprostane in EBC of children with problematic asthma. Eur Respir J 2010; 35:1364-1369.
17. Robroeks C, Rijkers G, Jobsis Q, et al. Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children. Clin Exp Allergy 2009; 40:77-84.
18. Fitzpatrick A, Teague W, Holguin F, et al. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J Allergy Clin Immunol 2009; 123:146-152.
19. Fitzpatrick A, Brown L, Holguin F, Teague W. Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma. J Allergy Clin Immunol 2009; 124:990-996.
20. Martinez F, Morgan W, Wright A, et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319:1112-1117.
21. Marguet C, Jouen-Boedes F, Dean T, Warner J. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough or cystic fibrosis. Am J Respir Crit Care Med 1999; 159:1533-1540. (Pubitemid 29227865)
22. Hauk P, Krawiec M, Murphy J, et al. Neutrophilic airway inflammation and association with bacterial lipopolysaccharide in children with asthma and wheezing. Pediatr Pulmonol 2008; 43:916-923.
23. Fitzpatrick A, Holguin F, Teague W, Brown L. Alveolar macrophage phago-cytosis is impaired in children with poorly controlled asthma. J Allergy Clin Immunol 2008; 121:1372-1378.
24. Huynh M, Malcolm K, Kotaru C, et al. Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. Am J Respir Crit Care Med 2005; 172:972-979. (Pubitemid 41476533)
25. Lex C, Payne D, Zacharasiewicz A, et al. Sputum induction in children with difficult asthma: safety, feasibility, and inflammatory cell pattern. Pediatr Pulmonol 2005; 39:318-324. (Pubitemid 40411531)
26. Lex C, Ferreira F, Zacharasiewicz A, et al. Airway eosinophilia in children with severe asthma. Predictive values of noninvasive tests. Am J Respir Crit Care Med 2006; 174:1286-1291. (Pubitemid 44913029)
27. Drews A, Pizzichini M, Pizzichini E, et al. Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children. Allergy 2009; 64:1597-1601.
28. Rabinovitch N. Urinary leukotriene E4. Immunol Allergy Clin N Am 2007; 27:651-664.
29. Rabinovitch N, Zhang L, Gelfand E. Urinary leukotriene E4 levels are asso-ciated with decreased pulmonary function in children with persistent airway obstruction. J Allergy Clin Immunol 2006; 118:635-640. (Pubitemid 44301392)
30. Rabinovitch N, Graber N, Chinchilli V, et al. Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma. J Allergy Clin Immunol 2010; 126:545-551.
31. Anderson G. Endotyping asthma: new insights into key pathogenic mechan-isms in a complex, heterogeneous disease. Lancet 2008; 372:1107-1119.